BamSEC and AlphaSense Join Forces
Learn More

Tribute Pharmaceuticals Canada Inc.

Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.4
from 8-K 2 pages Release of Security Interest in Intellectual Property
12/34/56
EX-10.3
from 8-K 3 pages Release of Security Interest in Intellectual Property
12/34/56
EX-10.3
from 8-K 54 pages Amended and Restated Share Subscription Agreement by and Among Aralez Pharmaceuticals Inc., Aralez Pharmaceuticals PLC, Tribute Pharmaceuticals Canada Inc., Pozen Inc., Qlt Inc. and the Other Co-Investors Identified on Schedule I Hereto Dated as of December 7, 2015
12/34/56
EX-10.2
from 8-K 12 pages Second Amended and Restated Registration Rights Agreement
12/34/56
EX-10.1
from 8-K 97 pages Second Amended and Restated Facility Agreement
12/34/56
EX-10.6
from 10-Q 1 page Addendum to Agreement Between Colorado Biolabs, Inc. and Medical Futures Inc. Dated November 19th, 2014
12/34/56
EX-10.5
from 10-Q 3 pages Amendment No. 1 to December 1, 2006 Distribution Agreement
12/34/56
EX-10.4
from 10-Q 10 pages Distribution Agreement
12/34/56
EX-10.3
from 8-K 54 pages Share Subscription Agreement by and Among Aguono Limited, Tribute Pharmaceuticals Canada Inc., Pozen Inc., Qlt Inc. and the Other Co-Investors Identified on Schedule I Hereto Dated as of June 8, 2015
12/34/56
EX-10.2
from 8-K 46 pages Facility Agreement
12/34/56
EX-10.1
from 8-K 14 pages Support Agreement
12/34/56
EX-10.5
from 10-K 3 pages Consulting Agreement
12/34/56
EX-10.4
from 10-K 12 pages Amended and Restated Executive Employment Agreement
12/34/56
EX-10.2
from 8-K 24 pages Executive Employment Agreement
12/34/56
EX-10.1
from 8-K 24 pages Executive Employment Agreement
12/34/56
EX-10.5
from 10-Q 7 pages Void After 4:00 P.M. (Toronto Time) on the 15th Day of July, 2016. Compensation Options
12/34/56
EX-10.4
from 10-Q 60 pages Warrant Indenture Providing for the Issue of Common Share Purchase Warrants Between Tribute Pharmaceuticals Canada Inc. - And - Equity Financial Trust Company Dated as of July 15, 2014
12/34/56
EX-10.3
from 10-Q 10 pages Intellectual Property Security Agreement
12/34/56
EX-10.3
from 8-K 7 pages Intellectual Property Security Agreement
12/34/56
EX-10.2
from 8-K 37 pages Guarantee and Collateral Agreement Dated as of August 8, 2013 Among Tribute Pharmaceuticals Canada Inc. as Grantor, and Swk Funding LLC, as Agent
12/34/56